TKNO: Alpha Teknova, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 520.28
Enterprise Value ($M) 527.52
Book Value ($M) 87.27
Book Value / Share 1.64
Price / Book 5.96
NCAV ($M) 9.10
NCAV / Share 0.17
Price / NCAV 57.18

Profitability (mra)
Return on Invested Capital (ROIC) -0.27
Return on Assets (ROA) -0.25
Return on Equity (ROE) -0.35

Liquidity (mrq)
Quick Ratio 3.94
Current Ratio 4.73

Balance Sheet (mrq) ($M)
Current Assets 45.93
Assets 124.10
Liabilities 36.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
07-19 13D Telegraph Hill Partners IV, L.P. 70.80 47.21

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-06 20,031 153,143 13.08
2025-02-05 69,498 183,746 37.82
2025-02-04 51,442 223,803 22.99
2025-02-03 30,969 135,211 22.90

(click for more detail)

Similar Companies
TARA – Protara Therapeutics, Inc. TBPH – Theravance Biopharma, Inc.
TCRX – TScan Therapeutics, Inc. TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io